000			01849 a2200433 4500
005			20250511204309.0
264		0	_c19920331
008			199203s 0 0 eng d
022			_a1053-8550
024	7		_a10.1097/00002371-199110000-00004 _2doi
040			_aNLM _beng _cNLM
100	1		_aYang, S C
245	0	0	_aPhenotype and cytolytic activity of mouse tumor-bearer splenocytes and tumor-infiltrating lymphocytes from K-1735 melanoma metastases following anti-CD3, interleukin-2, and tumor necrosis factor-alpha combination immunotherapy. _h[electronic resource]
260			_bJournal of immunotherapy : official journal of the Society for Biological Therapy _cOct 1991
300			_a326-35 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnimals
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntigens, CD _ximmunology
650	0	4	_aCytotoxicity Tests, Immunologic
650	0	4	_aImmunophenotyping
650	0	4	_aImmunotherapy _xmethods
650	0	4	_aInterleukin-2 _xtherapeutic use
650	0	4	_aLung Neoplasms _ximmunology
650	0	4	_aLymphocytes, Tumor-Infiltrating _ximmunology
650	0	4	_aMelanoma _ximmunology
650	0	4	_aMice
650	0	4	_aRecombinant Proteins _xtherapeutic use
650	0	4	_aRemission Induction _xmethods
650	0	4	_aSpleen _xcytology
650	0	4	_aSurvival Rate
650	0	4	_aTumor Cells, Cultured
650	0	4	_aTumor Necrosis Factor-alpha _xtherapeutic use
700	1		_aFry, K D
700	1		_aGrimm, E A
700	1		_aRoth, J A
773	0		_tJournal of immunotherapy : official journal of the Society for Biological Therapy _gvol. 10 _gno. 5 _gp. 326-35
856	4	0	_uhttps://doi.org/10.1097/00002371-199110000-00004 _zAvailable from publisher's website
999			_c1796340 _d1796340